FORT WORTH, Texas, July 22, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its second quarter 2025 financial results.
PALATINE, Ill., July 21, 2025 /PRNewswire/ --
CORNERSTONE BANCORP, INC.
SECOND QUARTER 2025 HIGHLIGHTS (At or for period ended 6/30/2025)
Income Statement Highlights
Consolidated net income was $2.8 million...
High-grade gold, copper, silver and tungsten assay results have been received for a further five holes from its ongoing drilling program designed to outline...
Reference is made to the stock exchange announcement published by Prosafe SE ("Prosafe" or the "Company") on 24 April 2025 where it was announced that Prosafe had agreed the terms of a recapitalization (the "Recapitalization") which, inter alia, includes a recapitalization of USD 193 million into 321,635,718 new shares in the Company (the "New Shares") and an offering of up to 17,868,651 warrants to shareholders in the Company as of 16 May 2025 as registered in the Euronex Securities Oslo VPS on the record date 20 May 2025 (the "Warrants"), subject to final approval being obtained by all lenders.
HOUSTON, July 16, 2025 /PRNewswire/ -- Nabors Energy Transition Corp. II ("NETD" or the "Company") (Nasdaq: NETD) announced today that its shareholders approved an...
NORTH BERGEN, NJ, July 16, 2025 (GLOBE NEWSWIRE) -- Free Flow, Inc. (OTC PK: FFLO), which is incorporated in the state of Delaware as Free Flow USA, Inc., today announced that the Company’s Accurate Investments, Inc subsidiary has entered into a contract to purchase a real estate investment property in New Jersey with existing and arranged highly-accredited tenants that would pay an approximate triple net lease amount of over $1,800,000 per annum against long term leases.
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.
Frontera May Purchase up to 3,502,962 Common Shares Representing Approximately 5% of the Company's Issued and Outstanding Common Shares
CALGARY, AB, July 15, 2025 /CNW/ - Frontera...
Frontera May Purchase up to 3,502,962 Common Shares Representing Approximately 5% of the Company's Issued and Outstanding Common Shares
CALGARY, AB, July 15, 2025 /PRNewswire/ - Frontera...